Raytheon Missiles and Defense, one of four business segments of Raytheon Technologies Corporation (NYSE: RTX), has been awarded a modification contract worth $263,717,654. 

This modification exercises options for the production and delivery of AIM-9X missile production Lot 23 requirements. The contract includes the production of 571 AIM-9X Block II tactical missiles, 48 captive air training missiles, all-up-round containers, spare advanced optical target detectors, captive air training missile guidance units, tactical sectionalization kits, and other related assets. This contract also covers non-recurring engineering associated with the Systems Improvement Program III transition to production activities.

The Naval Air Systems Command, located in Patuxent River, Maryland, is responsible for overseeing the contracting activity for this project.

On Friday, $RTX closed at $96.08, showcasing a positive gain of $1.99 (2.12%).

Automatic Data Processing, Inc. (Nasdaq: ADP), a leading provider of human resources management software and services, was initiated with a Neutral rating and a price target of $230 by UBS. 

With a closing price of $216.52 on Friday, this suggests a potential upside of $13.48 (6.22%) for $ADP, according to the investment firm's analysis.

Arrowhead Pharmaceuticals, Inc. (Nasdaq: ARWR), a biopharmaceutical company specializing in RNA interference therapeutics, had its price target raised from $52 to $59 by Piper Sandler. 

With $ARWR closing at $36.05 on Friday, this adjustment implies a potential upside of $22.95 (63.66%), based on the brokerage firm's view.

Kinsale Capital Group, Inc. (NYSE: KNSL), an insurance company focused on specialty lines, was upgraded from Underperform to Outperform, with its price target increased from $270 to $389 by BMO Capital Markets. 

Ending the week at $337.65, this adjustment suggests a potential upside of $51.35 (19.10%) for $KNSL, as per the analyst's view.

It is important to note that the potential upsides mentioned above are based on the perspectives of the respective brokerage firm, investment firm, or analysts. These estimates should be considered in conjunction with market fluctuations and individual investment decisions.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)